RECRUITING

Mobile App to Help Survivors of Childhood Cancer Navigate Long-Term Follow-Up Care

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This clinical trial studies the effectiveness of a newly developed survivorship mobile application (app) designed for survivors, or their caregivers, of childhood cancer to help them better navigate long-term follow-up care. The survivorship app provides survivors access to their treatment history and follow-up recommendations, improves knowledge of their diagnosis, treatment, risks, and recommended follow-up care by using a message notification. The ability to quickly connect and establish care planning may enhance adherence to recommended follow-up.

Official Title

Utilizing a Mobile App to Help Survivors of Childhood Cancer Navigate Long-Term Follow-Up Care

Quick Facts

Study Start:2022-11-29
Study Completion:2025-04-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05641961

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:Not specified
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:CHILD, ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Survivors of childhood cancer attending Survivorship Clinic at University of California, San Francisco (UCSF) OR caregivers of a childhood cancer survivor attending Survivorship Clinic at UCSF.
  2. * Must have a mobile device (smartphone or smart-tablet) with service plan.
  3. * Must have ability to read, write, and understand English language.
  1. * An individual who does not meet any of the criteria mentioned above will be excluded from participation in this study.

Contacts and Locations

Study Contact

Patricia Murphy, RN
CONTACT
(415) 476-2700
Patricia.Murphy@ucsf.edu

Principal Investigator

Robert Goldsby, MD
PRINCIPAL_INVESTIGATOR
University of California, San Francisco

Study Locations (Sites)

University of California, San Francisco
San Francisco, California, 94143
United States

Collaborators and Investigators

Sponsor: University of California, San Francisco

  • Robert Goldsby, MD, PRINCIPAL_INVESTIGATOR, University of California, San Francisco

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-11-29
Study Completion Date2025-04-30

Study Record Updates

Study Start Date2022-11-29
Study Completion Date2025-04-30

Terms related to this study

Additional Relevant MeSH Terms

  • Childhood Cancer
  • Hematopoietic and Lymphoid Cell Neoplasm
  • Malignant Solid Neoplasm